Yes, Treat with Benzathine Penicillin G
A patient presenting with ulcers (chancre) and an RPR titer of 1:2 should receive benzathine penicillin G 2.4 million units IM as a single dose for primary syphilis. 1
Clinical Reasoning
The presence of an ulcer (chancre) indicates primary syphilis, regardless of the low RPR titer. The RPR titer of 1:2 is actually quite typical for early primary syphilis—serologic tests may be negative or show low titers in the earliest stages of infection when the chancre first appears.
Standard Treatment Regimen
- Benzathine penicillin G 2.4 million units IM in a single dose is the definitive treatment for primary syphilis 1
- This regimen has been used effectively for four decades to achieve local cure (healing of lesions and prevention of sexual transmission) and prevent late sequelae 1
- The FDA label specifically indicates benzathine penicillin G for treatment of syphilis 2
Why the Low Titer Doesn't Change Management
The RPR titer of 1:2 should not deter treatment. In primary syphilis:
- Serologic tests may be negative or show low titers early in infection
- The clinical presentation (chancre) takes precedence over serologic findings
- Waiting for higher titers would delay necessary treatment and risk progression
Recent Evidence Supports Single-Dose Therapy
The most recent high-quality evidence from 2025 demonstrates that one dose of 2.4 million units benzathine penicillin G is noninferior to three doses for early syphilis, with a 76% serologic response rate at 6 months 3. This applies to both HIV-infected and HIV-uninfected patients.
Additional Management Considerations
- Test for HIV infection in all patients with syphilis 1
- Lumbar puncture is NOT routinely indicated for primary syphilis unless neurologic or ophthalmic symptoms are present 1
- Warn about Jarisch-Herxheimer reaction: approximately 24% of patients experience short-lived symptoms (myalgias, chills, weakness, feverishness) within 12 hours of treatment 4
Follow-Up Protocol
- Reexamine clinically and serologically at 6 months and 12 months 1
- Expect a 4-fold decline in RPR titer (from 1:2 to nonreactive) within 6 months as evidence of treatment success
- Treatment failure is indicated by persistent/recurrent symptoms or sustained 4-fold increase in titer 1
Common Pitfall to Avoid
Do not withhold treatment based on a low RPR titer. The clinical diagnosis of primary syphilis (presence of chancre) supersedes serologic findings. Early primary syphilis commonly presents with low or even negative serologic tests, and delaying treatment risks disease progression to secondary or latent stages.